92 related articles for article (PubMed ID: 6789566)
1. [The detection of apolipoproteins AI and B in the liver of patients with and without hyperlipoproteinemia (author's transl)].
Hopf U; Schwartzkopff W; Assmann G; Beger HG; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1981 Jun; 19(6):284-92. PubMed ID: 6789566
[TBL] [Abstract][Full Text] [Related]
2. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
3. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Zambon A; Brown BG; Deeb SS; Brunzell JD
J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of apolipoproteins A-I, A-II and B in alcoholism. Relation to the degree of histological liver damage, and to liver function tests.
Malmendier CL; Mailier EL; Amerijckx JP; Fischer ML
Hepatogastroenterology; 1983 Dec; 30(6):236-9. PubMed ID: 6427088
[TBL] [Abstract][Full Text] [Related]
5. Plasma apoproteins levels in chronic alcohol abuse.
Rosseneu M; Stellamans G; Vercaemst R; Belpaire F
Artery; 1982; 10(3):193-201. PubMed ID: 7103748
[TBL] [Abstract][Full Text] [Related]
6. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I
Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304
[TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma lipid concentrations and HDL subclasses.
Yang Y; Yan B; Fu M; Xu Y; Tian Y
Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
[TBL] [Abstract][Full Text] [Related]
8. [Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)].
Mertz DP; Suermann I; Göhmann E
MMW Munch Med Wochenschr; 1978 Aug; 120(34):1097-9. PubMed ID: 210375
[TBL] [Abstract][Full Text] [Related]
9. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
[TBL] [Abstract][Full Text] [Related]
10. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
[TBL] [Abstract][Full Text] [Related]
11. Effect of procetofen on serum lipids and apoproteins.
Capurso A; Mogavero AM; Taverniti R; Resta F; Pace L; Bonomo L
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):194-7. PubMed ID: 6715088
[TBL] [Abstract][Full Text] [Related]
12. [Interpretation of B and A apoproteins dosage in the acute accidents of the cerebral and coronary atherosclerosis. Age influence upon the results (author's transl)].
Bugugnani MJ; Haiat R; Fouyé H; Rémy A; Desoutter P
Ann Biol Clin (Paris); 1981; 39(3):131-4. PubMed ID: 6787958
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of lipids, lipoproteins and apolipoproteins concentrations in cord blood serum of newborns from rural and urban environments.
Pac-Kozuchowska E
Ann Agric Environ Med; 2007; 14(1):25-9. PubMed ID: 17655173
[TBL] [Abstract][Full Text] [Related]
14. [Serum thromboxane B2 and prostaglandin F2 alpha in familial combined hyperlipoproteinemia and familial hypercholesterolemia].
Sziegoleit W; Wichmann T; Block HU; Taube C; Mest HJ
Wien Klin Wochenschr; 1991; 103(8):227-31. PubMed ID: 1858388
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
Lijnen P; Celis H; Desager JP; Fagard R
J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
Al-Quobaili FA; Abou Asali IE
Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691
[TBL] [Abstract][Full Text] [Related]
17. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
[TBL] [Abstract][Full Text] [Related]
18. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.
Marcovina S; Packard CJ
J Intern Med; 2006 May; 259(5):437-46. PubMed ID: 16629849
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of lipids, apoproteins and lipoproteins in patients with coronary disease and in a control population].
Marzullo C; Michotey O; Bourderont D; Levy J; Jung S; Tissot J; Huber-Braun C; Dorr R
Ann Biol Clin (Paris); 1994; 52(10):717-20. PubMed ID: 7747879
[TBL] [Abstract][Full Text] [Related]
20. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
Kushwaha RS; Chait A; Hazzard WR
J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
